Results 81 to 90 of about 114,860,682 (209)

Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2‐negative breast cancer

open access: yesHistopathology, Volume 89, Issue 4, Page 670-686, October 2026.
Short‐course preoperative endocrine therapy induces histopathological and immunophenotypic changes in oestrogen receptor‐positive, HER2‐negative breast cancer. Proliferative response is independently associated with baseline genomic risk (MammaPrint) and progesterone receptor expression.
Claudia Grosse   +8 more
wiley   +1 more source

Pleomorphic Lobular Carcinoma in a Male Breast: A Rare Occurrence

open access: yes, 2010
Carcinoma of male breast is uncommon as it accounts for 0.7% of total breast cancer. The pathology of male breast cancer is remarkably similar to that of cancers seen in women.
Misra Vatsala   +5 more
core   +1 more source

High-Risk Benign Breast Lesions: An Ontario Health (Cancer Care Ontario) Recommendations Report

open access: yesCurrent Oncology
High-risk benign breast lesions are histological abnormalities that present in breast tissue, typically identified by screening or diagnostic imaging. The presence of invasive or in situ breast cancer can be confirmed or ruled out within these lesions ...
Andrea Eisen   +15 more
doaj   +1 more source

Coexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts: case report

open access: yesEuropean Journal of Medical Research, 2012
This report describes a rare case of coexistence of benign phyllodes tumor, which measured 9 cm in the right breast, and invasive ductal carcinoma of 6 cm in the left breast, synchronous and independent, in a 66-year-old patient.
Neto Guerino   +7 more
doaj   +1 more source

Current Perspectives on Lobular Neoplasia of the Breast

open access: yes, 2023
Purpose of Review To present current data on histopathologic types, imaging presentation, and management of lobular neoplasia of the breast. Recent Findings Non-invasive lobular neoplasia is a heterogeneous group of lesions, including classic lobular ...
Collado-Mesa, Fernando   +2 more
core   +1 more source

Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ

open access: yesChinese Clinical Oncology, 2016
The management of in situ lesions ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS) continues to evolve. These diagnoses now comprise a large burden of mammographically diagnosed cancers, and with a global trend towards more population-based screening, the incidence of these lesions will continue to rise.
Samilia, Obeng-Gyasi   +2 more
openaire   +2 more sources

O papel da mamografia no diagnóstico das patologias mamárias. [PDF]

open access: yes, 1994
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Tocoginecologia, Curso de Medicina, Florianópolis ...
Luca, Pedro Lemos de
core  

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

open access: yes, 1997
In breast cancer, inactivating point mutations in the E-cadherin gene are frequently found in invasive lobular carcinoma (ILC) but never in invasive ductal carcinoma (IDC).
Vos, C. B.   +8 more
core   +1 more source

Invasive lobular carcinoma of the male breast – a systematic review with an illustrative case study

open access: yes, 2017
Jenna-Lynn Senger,1 Scott J Adams,2 Rani Kanthan3 1Division of Plastic Surgery, University of Alberta, Edmonton, AB, Canada; 2College of Medicine, 3Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK, Canada ...
Senger JL, Adams SJ, Kanthan R
core  

Home - About - Disclaimer - Privacy